(Q58295801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

P C Frei

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

380-383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix?

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Isolated antibody to hepatitis B core is associated with hepatitis C virus co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

7 January 2021

Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

7 January 2021

Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a population with a high prevalence of hepatitis B

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

7 January 2021

Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

7 January 2021

A case of hepatitis B in a haemodialysis unit

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

7 January 2021

Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.210603.X

7 January 2021

10.1034/J.1600-0676.2001.210603.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903881%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference